intersting twist of Fatehttps://www.xconomy.com/national/2011/07/07/fate-therapeutics-trims-chemistry-staff-bets-on-biotech-drugs/
Fate Therapeutics Trims Chemistry Staff, Bets on Biotech Drugs
Fate Therapeutics, the high-profile stem cell startup in San Diego, has made some limited job cuts in recent months and changed strategy to focus on biotech drugs—instead of conventional small molecules—to coax stem cells into becoming a useful therapies.
Another company provides affirmation (by their actions) that SCT is doing things right.